CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer

NCT05585814 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Colorectal Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Bevacizumab
DRUG: Pembrolizumab

Sponsor

Shanghai Changzheng Hospital